Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

Psychotic Disorder Clinical Trial

Official title:

Three Year Follow up of a Randomised Controlled Trial of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00350493
• Other study ID #: 3Yr FollowUp
• Status: Completed
• Phase: Phase 4
• First received: July 6, 2006
• Last updated: September 25, 2008
• Start date: January 2005
• Est. completion date: February 2006

Study information

• Verified date: September 2008
• Source: The University of New South Wales
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: Department of Health and Ageing Therapeutic Goods Administration
• Study type: Observational

Clinical Trial Summary

This is a three year follow up of a previous study where researchers at UNSW and UNewc asked smokers with serious mental health problems to participate in a 12-month study, to assess whether intervention could assist people experiencing mental illness reduce their tobacco smoking.

Description:

Between 2001 and 2003, the School of Public Health and Community Medicine at the University of New South Wales carried out a large study with the Centre for Mental Health Studies at the University of Newcastle. The project asked people with serious mental health problems, who also smoked cigarettes, to participate in a 12-month study, which involved completing several questionnaires/other assessments over that time with a member of the research team. Around half of the participants in this study also received treatment for their smoking from the research team. This treatment involved weekly therapy with one member of the research team, and covered the relationship between smoking and mental illness, teaching people to cope with desires to smoke, how to recognise and avoid high risk situations for smoking, and how to plan alternative ways of coping with those situations where smoking usually occurred. In addition, nicotine patches were also available to assist people who made the decision to reduce their smoking. This study hoped to learn whether this new treatment could assist people experiencing mental illness reduce their tobacco smoking.

After three years, previous participants were invited to participate in another follow-up assessment to check-in with their current situation, their mental health and levels of smoking.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 298
• Est. completion date: February 2006
• Est. primary completion date: February 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 67 Years

Eligibility

Inclusion Criteria:

• Previous participants from the original study

Study Design

N/A

Related Conditions & MeSH terms

• Behavior, Addictive
• Mental Disorders
• Psychotic Disorder
• Psychotic Disorders

Locations

Country	Name	City	State
Australia	Centre for Mental Health Studies, University of Newcastle	Newcastle	New South Wales
Australia	School of Public Health and Community Medicine, University of New South Wales	Sydney	New South Wales

Sponsors (2)

Lead Sponsor	Collaborator
The University of New South Wales	Australian Government Department of Health and Ageing

Country where clinical trial is conducted

Australia,